sphingolipid synthesis, TM9SF2, LAPTM4A 23 we found that sphingolipids also mediate early events associated with T3SS 47 pathogenicity. Since antibiotics are contraindicated for the treatment of EHEC, 48 therapeutics targeting sphingolipid biosynthesis are a promising alternative, as they 49 could provide protection against both of the pathogen's key virulence factors. 50
Enterohemorrhagic Escherichia coli (EHEC) has two critical virulence factorsa type III 25 secretion system (T3SS) and Shiga toxins (Stx)that are required for the pathogen to 26 colonize the intestine and cause diarrheal disease. Here, we carried out a genome-wide 27 CRISPR/Cas9 loss-of-function screen to identify host loci that facilitate EHEC infection 28 of intestinal epithelial cells. Many of the guide RNAs identified targeted loci known to be 29 associated with sphingolipid biosynthesis, particularly for production of 30 globotriaosylceramide (Gb3), the Stx receptor. Two loci (TM9SF2 and LAPTM4A) with 31 largely unknown functions were also targeted. Mutations in these loci not only rescued 32 cells from Stx-mediated cell death, but also prevented cytotoxicity associated with the 33 EHEC T3SS. These mutations interfered with early events associated with T3SS and 34
Stx pathogenicity, markedly reducing entry of T3SS effectors into host cells and binding 35 of Stx. The convergence of Stx and T3SS onto overlapping host targets provides 36 guidance for design of new host-directed therapeutic agents to counter EHEC infection. 37 38 Importance 39 Enterohemorrhagic Escherichia coli (EHEC) has two critical virulence factorsa type III 40 secretion system (T3SS) and Shiga toxins (Stx)that are required for colonizing the 41 intestine and causing diarrheal disease. We screened a genome-wide collection of 42 CRISPR mutants derived from intestinal epithelial cells and identified mutants with 43 enhanced survival following EHEC infection. Many had mutations that disrupted 44 synthesis of a subset of lipids (sphingolipids) that includes the Stx receptor 45 globotriaosylceramide (Gb3), and hence protect against Stx intoxication. Unexpectedly, 46 Introduction 52 Enterohemorrhagic E. coli (EHEC) is a food-borne human pathogen that causes 53 diarrheal illness worldwide. Infection is often associated with bloody diarrhea that is 54 usually self-limited; however, 5-7% of cases progress to hemolytic uremic syndrome 55 (HUS), a life-threatening complication that can result in renal failure and neurological 56 sequelae (1). EHEC pathogenesis shares many features with that of enteropathogenic 57 E. coli (EPEC), another extracellular pathogen that colonizes the intestine. Successful 58 colonization by both species is dependent upon a type III secretion system (T3SS) that 59 enables tight adherence of bacteria to host epithelial cells by inducing characteristic 60 actin cytoskeletal rearrangements and loss of microvillus structure (attaching and 61 effacing (AE) lesions) (2). EHEC virulence is also markedly shaped by production of 62 Shiga toxins (Stx), variants of which are often present in multiple copies within the 63 EHEC genome. Translocation of Stx to tissues outside of the intestinal tract is thought 64 to underlie the development of HUS (3, 4) . 65
66
The EHEC T3SS injects a plethora of effector proteins into host cells, resulting in 67 alteration or disruption of numerous host cell processes. During infection, EHEC is 68 thought to target epithelial cells within the large intestine; however, a variety of cultured 69 cell lines have been used to characterize the activity of this system. In vivo and in vitro 70 studies have revealed that a key effector is the Translocated Intimin Receptor (Tir) (5). 71
Tir is inserted into the host cell membrane and serves as a receptor for the bacterial 72 adhesin, intimin (6). Interactions between intimin and Tir are also required for 73 recruitment and rearrangement of actin and other cytoskeletal proteins underneath 74 adherent bacteria, which results in characteristic actin-rich "pedestals." In animal 75 models, deletions of tir or eae (the intimin locus) and mutations that render the T3SS 76 inactive markedly reduce the pathogen's capacity to colonize the intestine and cause 77 disease (7, 8) . 78 79 Thirty eight bacterial proteins in addition to Tir have been confirmed as type 3 secreted 80 effector proteins in EHEC (9). Unlike structural components of the T3SS, individual 81 effector proteins are frequently not essential for bacterial virulence; although their roles 82 have not been fully defined, it is clear that effector proteins can act in redundant, 83 synergistic and antagonistic fashions (10). Key host processes modulated by EHEC 84 effectors include innate immunity, cytoskeletal dynamics, host cell signaling, and 85 apoptosis (11). EHEC effectors also restrict host cell phagocytosis of this extracellular 86 pathogen. Effectors undergo an ordered translocation and after its translocation, the 87 effector protein EspZ functions as a "translocation stop" that prevents unlimited effector 88 translocation and reduces infection-associated cytotoxicity (12). Compared to wt 89 infection, in vitro infection with espZ-deficient strains results in greater host cell 90 detachment, loss of membrane potential, and formation of condensed nuclei (13). 91 92 Stx and of the T3SS effectors, have been identified, to date, unbiased genome-wide 117 screens for EHEC susceptibility loci have not been reported. Recently, such screens 118 have become possible, given the advent of CRISPR/Cas9-based libraries of host 119 mutants whose composition can be monitored using high throughput DNA sequencing. 120
We recently used this approach to screen for host factors that mediate susceptibility to 121 V. parahaemolyticus' two T3SS, and identified several host processes not previously 122 linked to T3SS activity (23). The efficiency and power of this approach (24, 25), 123 prompted us to adopt this approach to identify mutants with heightened resistance to 124
EHEC. 125 126
Here, we identify and characterize intestinal epithelial cell mutants that become 127 enriched following library infection with an EHEC strain producing an active T3SS as 128 well as Stx. Although minimal overlap between the action of the T3SS and Stx have 129 previously been reported, we identified several host loci and processes that are required 130 contribute to susceptibility to EHEC infection in the HT-29 colonic epithelial cell line 140 using the Avana library of sgRNAs (23). This library contains four sgRNAs targeting 141 each of the annotated human protein coding genes (26). Host cells were infected with a 142 espZ derivative of EHEC strain EDL933 (which carries genes encoding both Stx1 and 143 Stx2). The espZ mutation heightens T3SS activity and increases host cell death 144 associated with infection by EHEC (13) ( Fig. S1A ). We anticipated that if we could 145 increase the toxicity of the EHEC T3SS ( Fig. S1B ), we would enhance the screen's 146 selective pressure and yield greater enrichment of host cell mutants resistant to this key 147 virulence system. Although Stx1 and Stx2 were also produced under infection 148 conditions ( Fig. S1C ), initial toxicity assays using purified toxin suggested that they 149 would not exert substantial selective pressure during the screen. In contrast to infection 150 of cells with espZ EHEC, which resulted in marked (~80%) host cell death by the end 151 of the infection period ( Fig. 1AB) , a corresponding 6-hour treatment of cells with purified 152 toxin exceeding the amount detected during infection had minimal effect on viability 153 Avana guide RNAs were infected for 6 hr with espZ EHEC at an MOI of 100 ( Fig. 1A) . 157
Following infection, resistant cells were cultured in the presence of antibiotics until 158 reaching ~70% confluency (~5 days), then reseeded and reinfected. Genomic DNA was 159 isolated from a fraction of the surviving population after each of the four rounds of 160 infection as well as from the initial uninfected cells, and high throughput sequencing of 161 integrated sgRNA templates was performed to indirectly quantify the abundance of the 162 associated mutants. We found that as our screen progressed, as would be expected for 163 a library under strong selection, representation became biased toward a subset of 164 enriched genes ( Fig. S2A ). Statistical analysis was performed using the STARS 165 algorithm, which integrates data from independent guides targeting the same gene to 166 identify the most enriched genotypes (26). 167
168
We identified 13 loci with statistically significant enrichment (p< 0.001) in both libraries 169 after 4 rounds of infection ( Fig. 2A ). Unexpectedly, given our results with purified toxin, 170 more than half of the enriched loci encoded factors associated with sphingolipid 171 biosynthesis, and many were closely connected to synthesis of Gb3, the Stx receptor 172 ( Fig. 2B ). For example, hits included the Golgi-localized enzymes A4GALT, which 173 catalyzes the final step in Gb3 synthesis; B4GALT5, which catalyzes production of the 174 A4GALT substrate lactosylceramide; and UGCG, which converts ceramide (a precursor 175 for all glycosphingolipids) into glucosylceramide. Additional hits included the ER-176 localized SPTLC2, SPTSSA, and KDSR, all of which lie on the ceramide synthesis 177 pathway, and ARF1, which indirectly regulates intracellular trafficking of 178 glucosylceramide (27). 179 180 Enriched loci also included two genes, TM9SF2 and LAPTM4A, whose functions are 181 largely unknown. Although both are members of larger gene families of structurally 182 related proteins, only guide RNAs targeting these particular family members were found 183 to be enriched, suggesting that they have specific functions conferring susceptibility to 184 transmembrane protein required for the Golgi localization of NDST1, a sulfotransferase 186 (28). Its homologs in Drosophila (TM9SF2/4) and Dictyostelium (Phg1A/Phg1C) have 187 been linked to innate immunity and membrane protein localization (29, 30). LAPTM4A 188 has been reported to encode a transmembrane protein localized to lysosomes and late 189 endosomes. It has been linked to intracellular transport of nucleosides, multidrug 190 resistance, and maintenance of lysosomal integrity (31-34). In addition to the 191 enrichment of guides targeting TM9SF2, LAPTM4A, and genes related to sphingolipid 192 biosynthesis, our analysis detected enrichment for guides targeting several genes 193 associated with cancer and cell proliferation (MLLT3, TFAP4, ZNF217, and DUSP6) 194
The prominence among our hits of Gb3-related genes was unanticipated, because our 197 preliminary studies suggested that T3SS rather than Stx would exert the strongest 198 selective pressure in our screen. T3SS from several organisms have been hypothesized 199 to associate with lipid rafts (39-41), transient membrane microdomains which typically 200 are enriched in sphingolipids (including Gb3) (19); however, studies of T3SS activity 201 and host membrane components have generally focused on the importance of 202 cholesterol, and a role for Gb3 in EHEC pathogenesis beyond that of Stx receptor has 203 not been reported. To more precisely define the contribution of screen hits to 204 susceptibility to EHEC infection, we developed assays that enabled the effects of Stx 205 and T3SS on HT-29 cells to be investigated independently. Host cells were infected in 206 parallel with an espZ, an espZ escN mutant (which lacks an ATPase essential for 207 T3SS activity), an espZ stx1 stx2 mutant (stx, which does not produce Stx1 or 208 Stx2), or mock infected, and the number of host cells present after 1 or 5 days of 209 infection was determined ( Fig. S1B) . These experiments revealed similar marked 210 declines in abundance of HT-29 cells 1 day post-infection with the type 3-active espZ 211 or espZ stx EHEC (to <20% of that seen in mock infected cells; Fig. 1B) ; in contrast 212 the type 3-deficient but toxin-producing espZ escN infection had no significant effect 213 on host cell abundance at this time point ( Fig. 1B ). However, in the subsequent 4 days, 214
there was a marked difference in growth between cells infected with the espZ vs. 215 espZ stx strains. Population expansion of cells previously exposed to toxin (espZ 216 infection) was far slower than that of cells that were never exposed to the toxin (espZ 217 stx infection) ( Fig. 1C, Fig. S1B ). The abundance of HT-29 cells infected with the 218 espZ escN strain also differed significantly from that of mock infected cells by day 5, 219 likely further reflecting the consequence of toxin exposure at this time point. Collectively, 220 these analyses demonstrate that the impact of T3SS is most clearly evident 1 day post 221 infection, and can be differentiated from that of toxin via infection with the espZ stx 222 strain. In contrast, the effects of Stx are delayed and become more apparent 5 days 223 post infection, and can be assayed in infection with the T3SS-deficient espZ escN 224 strain. Given that our screen included multiple rounds of 5-day outgrowth following 225 infection (during which effects of Stx could manifest), we conclude that the screen 226 enriched for mutants resistant to Stx as well as T3SS. with espZ EHEC. In comparison to the HT-29 Cas9 control strain, all but one mutant 232 (ARF1) had significantly enhanced abundance at 5 days post-infection ( Fig. 2C) , 233
suggesting that our selection and analysis yielded robust and reliable data regarding 234 susceptibility to EHEC infection. 235 236
Sphingolipid biosynthesis facilitates T3SS killing 237
Because the hits predicted to be involved in cell proliferation (i.e. DUSP6, TFAP4, 238 ZNF217 and MLLT3) were less likely to be involved in EHEC pathogenesis per se, we 239 chose to focus further studies on a subset of the sphingolipid biosynthesis mutants and 240 on mutants in the largely uncharacterized loci TM9SF2 and LAPTM4A. In particular, we 241 focused on factors mediating synthesis of glycosphingolipids, particularly A4GALT, 242 which should only have impaired production of Gb3 and other globo-series 243 glycosphingolipids (42), and UGCG, which is required for synthesis of all 244 glycosphingolipids except galactosylceramines (43). ARF1 was also included, due to its 245 contribution to intracellular trafficking of UGCG's product from the cis-medial Golgi to 246 the trans Golgi network, where B4GALT5 and A4GALT are found (44). To assess the 247 bacterial factors underlying the enrichment of these loci, mutants were first infected with 248 the espZ stx strain or mock infected, and cell abundance was assessed one day 249 results suggest that these mutations confer resistance to espZ stx infection by 253 protecting against the effects of EHEC's T3SS, and thus that associated loci may play a 254 role in the host cell response to T3SS. Of these factors, only ARF1 has previously been 255 linked to T3SS-mediated processes; it is thought to facilitate insertion of the T3SS 256 translocon during Yersinia infection (45) but has not been linked to T3SS activity in 257
EHEC. 258 259
The first effector translocated by EHEC's T3SS -Tiris essential for the activity of this 260 secretion system. In the absence of Tir, translocation of additional effectors does not 261 occur, nor does the characteristic cytoskeletal rearrangement and formation of 262 membrane "pedestals" underneath adherent bacteria (5, 46). Tir translocation can be 263 assessed using a Tir-CyaA reporter fusion protein, followed by measurement of 264 intracellular cAMP levels (47). We monitored translocation of this reporter, which is 265 dependent on an intact T3SS, from wt EHEC into control HT-29 Cas9 cells and mutants 266 that appeared resistant to the effects of T3SS. These experiments revealed significantly 267 lower Tir translocation into all mutants than into control HT-29 cells, ranging from ~70% 268 (A4GALT) down to ~10% (LAPTM4A) of wt levels ( Fig. 3B ). Consistent with this 269 observation, immunofluorescence microscopy of wt and mutant HT-29 cells infected 270 with wt EHEC revealed markedly fewer adherent bacteria and associated actin-rich 271 pedestals. While EHEC formed pedestals on ~80% of infected wt HT-29 cells, pedestals 272 were detected on only 18-35% of infected mutants tested, and fewer pedestals were 273 generally observed per mutant cell ( Fig. 3CDE, Fig. S3A ). Collectively, these results 274 indicate that the mutations rendering HT-29 cells less susceptible to the cytotoxic 275 effects of EHECs T3SS all limit early steps in the T3SS effector translocation process, 276 although they do not fully disrupt this process. These results also demonstrate that the 277 mutants identified in our screen are protective against EHEC even when its T3SS 278 activity has not been augmented by mutation of espZ. 279 280 EHEC's T3SS machinery and associated effectors are similar to those of 281 enteropathogenic E. coli (EPEC), a related pathogen that does not produce Shiga toxin 282 but that also requires its T3SS to colonize and cause disease in the human intestine 283 (48). We investigated whether the mutations that protect HT-29 cells from EHEC 284 infection also render HT-29 less susceptible to EPEC. Wt and mutant HT-29 cells were 285 infected with an EPEC espZ mutant that, like its EHEC counterpart, is reported to have 286 increased cytotoxicity relative to the wt strain (13, 49) ( Fig. S3B ). All 5 mutants tested 287 exhibited increased survival compared to the wt cells at 1 day post infection, and this 288 increase was linked to the presence of a functional T3SS ( Fig. S3C ). Survival of the 289 TM9SF2 and ARF1 mutants was particularly enhanced, with the number of infected 290 cells nearing 50% of the mock infected controls, compared to the ~5% observed with wt 291 HT-29. Overall, our observations suggest that host glycosphingolipids modulate T3SS-292 mediated cytotoxicity for both pathogens, although pathogen reliance on particular 293 sphingolipids is not necessarily conserved. For example, the absence of A4GALT had a 294 dramatic effect on EHEC cytotoxicity, but only a modest influence on EPEC cytotoxicity. 295
Additionally, our results suggest that TM9SF2 may play a conserved role in facilitating 296 the activity of the EHEC and EPEC T3SS. 297 association within lipid rafts is important for Stx binding (50), and our screen's 300 identification of numerous sphingolipid-related loci, we hypothesized that TM9SF2 and 301 LAPTM4A mutants might be less susceptible to EHEC infection due to alterations in 302 lipid raft production or dynamics. To explore these possibilities, we compared the 303 trafficking in control, TM9SF2 and LAPTM4A cells of a chimeric GPI-anchored GFP 304 construct (GPI-GFP), which is transported to the plasma membrane where it becomes 305 enriched in lipid rafts (51). Cell surface fluorescence was similarly homogenous in all 306 three genetic backgrounds, and we could not detect consistent differences in steady 307 state plasma membrane fluorescence between the 3 samples ( Fig. S3D ). To determine 308 if kinetics of trafficking and insertion might nevertheless differ between wt and mutant 309 cells, we performed quantitative photobleaching. The rate of signal decay was similar 310 for all 3 backgrounds, suggesting that bulk plasma membrane trafficking and lipid raft 311 insertion is not grossly disrupted in TM9SF2 and LAPTM4A cells ( Fig. S3E ). Further 312 studies will be needed to define the precise means by which these mutations, as well as 313 others tested above, limit susceptibility to EHEC and EPEC's T3SS. 314 315 LAPTM4A and TM9SF2 are required for Gb3 biosynthesis 316
As noted above, the effects of Stx on HT-29 abundance were evident 5 days post-317 infection, and could be clearly distinguished from those of EHEC's T3SS through 318 infection with the Stx+ T3SS-deficient escN mutant (Fig. 1C ). Therefore, we also 319 compared the abundance of wt HT-29 cells and several mutants from our panel after 320 challenge with the escN strain. As anticipated, mutants lacking the sphingolipid 321 production) were far less susceptible to escN infection than wt HT-29 cells; at 5 days 323 post infection, the abundance of these mutants did not differ from that of mock-infected 324 controls ( Fig. 4A) . Intriguingly, the TM9SF2 and LAPTM4A mutants were also 325 significantly more abundant than wt cells by 5 days post escN infection, suggesting 326 that these factors not only contribute to resistance to T3SS-mediated cytotoxicity, but 327 also could be host factors facilitating intoxication. 328
329
To begin to explore the means by which TM9SF2 and LAPTM4A mutations protect 330 against Stx, we tested the capacity of mutants to bind to fluorescently tagged toxin. As 331 controls, we also assayed A4GALT and UGCG mutants, which are known to be 332 completely deficient in Gb3 production, and hence cannot bind Stx. Flow cytometry 333 analyses, which were performed both in HT-29 ( A4GALT mutant cells (which produce normal amounts of GM1) ( Fig. S4B ). As expected, 355 the UGCG cells showed a far more marked decrease in binding to cholera toxin, since 356 UGCG is required for synthesis of GM1 (43). Collectively, these observations suggest 357 that the TM9SF2 and LAPTM4A mutants' deficiencies in Stx binding reflect relatively 358 specific reductions in production of Gb3 or related globo-series glycosphingolipids, 359 rather than deficiencies that consistently impair synthesis or trafficking to the cell 360 membrane of multiple surface receptors. Coupled with our analysis of the set of mutants 361 that display reduced sensitivity to T3SS-mediated cytotoxicity, these observations 362 suggest that reduced production of Gb3 likely contributes to the TM9SF2 and LAPTM4A 363 mutants' resistance to the effects of EHEC's T3SS as well as to Stx. 364
365
To gain greater insight into the mechanism by which TM9SF2 and LAPTM4A enable 366 infection by EHEC, we determined their subcellular localization in HeLa cells via 367 confocal microscopy. Consistent with previous reports (28), we found that TM9SF2 co-368 localized with GM130, a Golgi matrix protein ( Fig. 5A) . A subset of fluorescence 369 emanated from nucleoli, potentially resulting from non-specific primary antibody binding, 370
though Stx has been reported to be actively transported into nucleoli (53). 371
Unexpectedly, as prior studies localized LAPTM4A to lysosomes (31-34), we found that 372 a LAPTM4A-GFP fusion protein localized to the Golgi, like TM9SF2 ( Fig. 5A) . of as functionally independent. However, our CRISPR/Cas9-based screen for host 400 mutants with reduced susceptibility to EHEC infection uncovered a remarkable overlap 401 in host factors that mediate the response to these bacterial products. The screen for 402 mutations enriched after infection with Stx+ and T3SS+ EHEC identified numerous loci 403 known to be associated with sphingolipid and glycosphingolipid biosynthesis, in 404 particular factors required for production of the Stx receptor Gb3, as well as two loci 405 (TM9SF2 and LAPTM4A) with largely undefined cellular roles that were also required 406 for toxin binding. Unexpectedly, mutants lacking these factors are also less susceptible 407 to cytotoxicity associated with EHECs T3SS. These mutations interfered with early 408 events associated with T3SS and Stx pathogenicity, markedly reducing entry of T3SS 409 effectors into host cells and binding of Stx. Although the means by which these host loci 410 and the processes associated with them are exploited by EHEC are not fully 411 understood, the convergence of Stx and T3SS onto overlapping targets raises intriguing 412 possibilities for design of therapeutic agents countering EHEC infection. 413
414
Previous studies of Stx and EHEC T3SS have characterized some of the pathways 415 through which these factors act upon host cells, such as the binding and retrograde 416 transport that enables Stx to reach its intracellular target, the stress responses induced 417 by Stx, the processes underlying formation of pedestals, and the targets and 418 mechanisms of effectors (55-58). Notably, our findings suggest that disruption of only a 419 subset of host genes provides protection against cytotoxicity when both virulence 420 factors are present. Interestingly, we identified loci that influence early steps within 421 virulence pathways, e.g., loci that are required for Stx binding to host cells or T3SS 422 effector translocation rather than loci that mediate toxin trafficking (e.g., clathrin, 423 dynamin, SNX1/2) (18) or interact with translocated effectors (e.g., N-WASP, IRTKS, 424
IRSp53) (58-60). Such proximal factors have also been identified in other genome-wide 425 CRISPR screens for host mutants resistant to cytotoxicity by other pathogens. For 426 example, a Yersinia RNAi screen and our Vibrio parahaemolyticus CRISPR screen 427 yielded loci that reduced effector translocation (23, 45). For EHEC virulence factors, 428 disrupting early steps in their interactions with host cells may be particularly protective 429 because these virulence factors disrupt multiple cellular processes once internalized; for 430 example, inactivation of the host response to a single T3SS effector may still leave cells 431 vulnerable to the activity of other growth-interfering effectors. 432 also likely identified in our screen because of the previously unrecognized overlap 435 between host factors utilized by T3SS and Stx at the start of their encounters with 436 epithelial cells. We found that mutants with disrupted synthesis of Gb3, which were 437 expected to be resistant to Stx-mediated growth inhibition, also exhibited an unexpected 438 reduction in their sensitivity to T3SS-mediated cytotoxicity that was associated with 439 reduced translocation of Tir. A majority of these mutants also exhibited reduced 440 susceptibility to EPEC infection, suggesting that common host processes may mediate 441 the actions of EHEC and EPEC's related T3SS. 442 443 Although many mutants identified by our screen share the characteristic of lacking Gb3, 444 it is unlikely that this deficit is the sole factor underlying their resistance to T3SS. 445
Mutants lacking A4GALT, UGCG, TM9SF2 and LAPTM4A appear equally devoid of 446 extracellular Gb3 in assays of Stx binding; however, they exhibit varying degrees of 447 resistance to espZ EHEC. T3SS resistance is also not fully correlated with the extent 448 to which Tir translocation into these cells is reduced. These observations suggest that 449 the reduction in Gb3 levels is associated with additional cellular changes (e.g., in overall 450 sphingolipid homeostasis, membrane/lipid raft composition, or intracellular trafficking) 451 that also modulate the host response to EHEC infection. 452
453
The means by which mutations in TM9SF2 and LAPTM4A prevent accumulation of Gb3 454 remain to be determined. We found that both proteins are localized within the Golgi, 455 raising the possibility that they modulate the activity, localization, or transport of 456 was previously found to regulate the localization of NDST1, a Golgi localized enzyme 458 that catalyzes N-sulfation of heparan sulfate, and to be required for accumulation of 459 NDST1's reaction product (28). TM9SF2 and the associated heparan sulfate N-sulfation 460 are important for host cell binding and entry by CHIKV virus (28); however, the absence 461 of other hits associated with heparan sulfate in our screen suggests that this phenotype 462
is not related to our results. Minor abnormalities in several other glycosylation pathways 463
were also associated with TM9SF2 disruption, but the underlying mechanism was not 464 determined. We found that TM9SF2 is not required for correct localization or 465 accumulation of A4GALT, suggesting that TM9SF2 may act prior to the terminal step of 466
Gb3 synthesis. Similarly, LAPTM4A mutation did not appear to modulate A4GALT 467 production or localization. It is unclear why previous studies have observed LAPTM4A 468 in lysosomes and late endosomes rather than the Golgi localization that we detected; 469 further studies will be needed to dissect the targeting and activity of LAPTM4A and its 470 relationship to production of Gb3. Protein annotation and studies in the mouse homolog 471 (MTP) suggest LAPTM4A may be involved in intracellular transport of nucleosides (61). 472
Together with its Golgi localization shown herein, LAPTM4A could be involved in 473 transporting activated sugars to the Golgi lumen, to supply precursors for Gb3 474
biosynthesis. 475 476
Although EHEC is susceptible to common antibiotics, antibiotic treatment is generally 477 contraindicated during EHEC infection, as antibiotics can increase production and 478 release of Stx, leading to the development of HUS (62). A variety of alternative 479 therapies have been proposed to counter the effects of toxin, including compounds that 480 sequester or neutralize toxin, block its binding to host cells, or disrupt toxin 481 internalization, processing, or intracellular activity (63). Their activity has largely been 482 tested in toxin-treated cell lines; a few have also been studied in animal models, but not 483 in the context of EHEC infection. Our results suggest that a subset of these compounds, 484
namely those that alter production of Gb3, may reduce pathogenesis associated with 485 
Materials and Methods

494
Bacterial strains, plasmids and growth conditions 495
All bacterial strains and plasmids used in this study are listed in Table S1 . Primers used 496 in strain construction are shown in Table S1 . Bacterial strains were cultured in LB 497 medium or on LB agar plates at 37°C unless otherwise specified. Antibiotics and 498 supplements were used at the following concentrations: carbenicillin: 50μg/ml; 499 ampicillin: 100ug/mL; chloramphenicol: 20μg/ml; kanamycin: 50μg/ml; streptomycin: 500 200μg /ml; IPTG: 1ug/ml. The EHEC espZ deletion mutant was constructed by allelic 501 exchange using a derivative of the suicide vector pDM4 that included espZ-flanking 502 mediated recombination (65). 504
Eukaryotic cell lines and growth conditions 505
HT-29, HeLa and 293T cells and their derivatives were cultured in DMEM supplemented 506 with 10% fetal bovine serum. Cells were grown at 37°C with 5% CO2 and routinely 507 passaged at 70-80% confluency; media was replenished every 2-3 days. 508
Positive selection screen using the HT-29 CRISPR AVANA libraries 509
The HT-29 libraries were constructed as described (23) were washed 3 times with 1X DPBS to remove nonadherent bacteria, then replenished 524 with fresh media supplemented with 1X antibiotic-antimycotic solution (ABAM) (Gibco-525 containing 100ug/mL streptomycin) and gentamicin 100ug/ml (Gent) ("stop medium"). 526
After overnight incubation, fresh "stop medium" was added to each flask. Flasks were 527 monitored daily by inverted light microscopy to follow the recovery of survivor cells. 528
Upon reaching 70% confluency, the cells were trypsinized, pooled and re-seeded for the 529 next round of infection, always keeping a minimum number of 80*10 6 cells to maintain a 530 coverage of at least 1000X. The infection and selection procedure was repeated for the 531 second, third and fourth rounds of infection. Additionally, a subset of cells from each 532 population were used for preparation of genomic DNA. 533 534
Genomic DNA preparation, sequencing and STARS analyses of screen results 535
Genomic DNA (gDNA) was extracted from 100x10 6 input cells (uninfected) and after 536 each round of infection with EHEC espZ (rounds 1, 2, 3 and 4) using the Blood and 537
Cell Culture DNA Maxi Kit from Qiagen. The gDNA was subjected to PCR to amplify 538 guide RNA sequences as previously described (26). The read counts were first 539 normalized to reads per million within each condition by the following formula: reads per 540 sgRNA/total reads per condition × 10 6 . Reads per million were then log2-transformed by 541
first adding 1 to all values, in order to take the log of sgRNAs with zero reads. For 542 analyses, the log2 fold-change of each sgRNA was determined relative to the input 543 sample for each biological replicate (Table S2 ). The STARS algorithm for CRISPR-544 based genetic perturbation screens was used to evaluate the rank and statistical 545 significance of the candidate genes as described (26). 546
547
The sgRNA sequences used for construction of HT-29 Cas9 mutant cells are shown in 549   Table S3 . All sgRNA oligo sequences were obtained from Integrated DNA Technologies 550 and cloned into the pLentiGuide-Puro plasmid as previously described (23). Briefly, 5μg 551 of plasmid pLentiGuide-Puro was digested with BmsBI (Fermentas) and purified using 552 the QIAquick Gel extraction kit. Each pair of oligos was annealed and phosphorylated 553 with T4 PNK (NEB) in the presence of 10X T4 DNA ligase buffer in a thermocycler with 554 the following parameters: i) incubation for 30 minutes at 37°C, ii) incubation at 95°C for 555 5 min with a ramp down to 25°C at 5°C per minute. Oligos were then diluted 1:200 and 556 1μl of the diluted oligo mixture was ligated with 50ng of BsmBI digested plasmid. 557
Ligations were transformed into STBL3 bacteria, and transformed clones were checked 558 by PCR and DNA sequencing. sgRNAs cloned into pLentiGuide-Puro were transduced 559 into HT-29 Cas9 cells as described below, and after 10 days of selection with 560
Puromycin (1μg/ml), the extent of disruption of the targeted gene was analyzed by 561 immunoblotting for the corresponding gene product or Sanger sequencing (Fig. S2C) . 562
Lentivirus Preparation and Transductions 563
Lentiviral transductions were performed as previously described (23). Briefly, all 564 lentiviruses were made by transfecting 293T cells using TransIT-LT1 transfection 565 reagent, the lentiviral packaging plasmids psPAX2 and pCMV-VSVG and the 566 corresponding cargo plasmid according to the manufacturer's protocol. 48h following 567 transfection, 293T culture supernatant was harvested, filtered through a 0.22μm pore 568 filter, and added to target HT-29 or HeLa cells grown to 70-80% confluency in 6-well 569 plates; a second virus supernatant were harvested 72 hr after transfection and added to 570 target cells. After each virus' supernatant addition to HT-29 cells, spin infection was 571 performed by adding 8μg/ml polybrene and spinning the 6-well plates were at 1600g for 572 2h at 30°C; HT-29 cells were then returned to 37°C. Puromycin selection for positive 573 transductants was initiated the following day. For transduction of HeLa cells, spin 574 infection was not performed. 575 576
Cell survival assays 577
For cell survival assays, 5x10 5 HT-29 cells were seeded into 6-well plates and grown for 578 48 hours in DMEM supplemented with 10% FBS. EHEC (or EPEC) strains for infections 579 were prepared as for library infections described above. HT-29 cells were infected at an 580 MOI=100 (or with uninoculated media in the case of mock infection), with media 581 changes and infection termination as for library infection. Mock infected cells were fed 582 but not passaged during the outgrowth period. Following infection and outgrowth for 1 or 583 5 days, cells were quantified by Trypan Blue (0.4%trypan blue) exclusion using a 584
Countess II Automated Cell Counter (Thermo Fisher Scientific). Cell survival after EPEC 585 infection was measured 4 hr post-infection. 586 587
Stx cytotoxicity assay and measurement of Stx released during infection 588
HT-29 cells were seeded at 1x10 6 cells/ well the day before the assay. Cell monolayers 589 were then exposed to a range of concentrations of pure Stx1 or Stx2 holotoxins for 6 590 hours. Cell survival was measured by Trypan Blue exclusion as described above, then 591 % of survival was calculated in comparison to HT-29 controls that did not receive toxin 592 treatment. Stx released during infection of HT-29 cells at 3hr and 6hr was measured by 593 ELISA, as described (66). 594 595
Tir Translocation Assays 596
The Tir translocation assay was performed as previously described (47). Briefly: HT-29 597 cells were plated at 1x10 5 cells/well in 96 wells and assayed at confluency. EHEC 598 strains harboring Tir-CyaA fusion or CyaA vector control were grown in LB overnight 599 then diluted 1:100 in DMEM and grown to OD600 = 0.6 shaking at 37C. Cells were 600 infected with MOI 100:1 for 90 minutes; cAMP was measured by ELISA using Biotrack 601 cAMP kit (Amersham) according to manufacturer's instructions. 602 603
Immunoblot analyses 604
Mammalian cell lysates were prepared with RIPA buffer and protein concentrations 605 were determined using BCA protein assay. 10ug of protein lysate was mixed with 606
NuPAGE LDS sample buffer (Invitrogen) with 50mM DTT, separated by NuPAGE Bis-607
Tris gel electrophoresis and transferred to nitrocellulose membranes. Antibodies and 608 concentrations used are listed in KEY RESOURCES TABLE. Blots were developed with 609 the SuperSignal West Pico ECL kit, and imaging was performed on the Chemidoc 610 Touch Imaging System (Biorad). 611
Immunofluorescence 612
HT-29 cells or HeLa cells were seeded in 12-well plates on 18mm glass coverslips or 4-613
well chambers (Mat-TEK). Cells were fixed with 2% paraformaldehyde (PFA) for 20 614 minutes at room temperature, washed with 1X PBS 3 times, then permeabilized with 615 were subjected to combined fixation and permeabilization in ice cold methanol for 10 617 minutes). Cells were blocked in 5% normal goat serum in PBS (blocking buffer) for 1 618 hour, followed by overnight incubation with primary antibodies (Table S4 ) at 4°C. Cells 619 were then washed 3 times with PBS followed by incubation with fluorescently-labeled 620 secondary antibody for 1 hour at room temperature. Cells were counterstained with 621
Alexa-568 Phalloidin and DAPI for actin cytoskeleton and nuclei, respectively. For 622 extracellular binding of Alexa-488-tagged Stx, cells were not permeabilized; for 623 intracellular binding, cells were permeabilized and stained as described above. 
